Previous Article | Next Article ![]()
Journal of Virology, November 1998, p. 9157-9165, Vol. 72, No. 11
Graduate Institute of Life Sciences,
Received 9 April 1998/Accepted 14 August 1998
Infection with the wild-type baculovirus Autographa
californica multiple nuclear polyhedrosis virus
(AcMNPV) results in complete death of Spodoptera
frugiperda (Sf) cells. However, infection of Sf cells with
AcMNPV carrying a mutation or deletion of the apoptotic
suppressor gene p35 allowed the cloning of surviving Sf
cells that harbored persistent viral genomes. Persistent infection established with the virus with p35 mutated or deleted was
blocked by stable transfection of p35 in the host genome or
by insertion of the inhibitor of apoptosis (iap) gene into
the viral genome. These artificially established persistently
virus-infected cells became resistant to subsequent viral challenge,
and some of the cell lines carried large quantities of viral DNA
capable of early gene expression. Continuous release of viral progenies
was evident in some of the persistently virus-infected cells, and
transfection of p35 further stimulated viral activation of
the persistent cells, including the reactivation of viruses in those
cell lines without original continuous virus release. These results
have demonstrated the successful establishment of persistent
baculovirus infections under laboratory conditions and that their
establishment may provide a novel continuous, nonlytic baculovirus
expression system in the future.
Baculoviruses are a diverse group of
common insect pathogens that primarily infect the order
Lepidoptera. These viruses contain circular double-stranded
DNA genomes of 90 to 160 kb (6, 30, 38, 41). They infect
insect cells productively and generate numerous viral progenies.
Persistent baculovirus infection has been studied less than productive
infection. Persistent viral infection generates sporadic outbreaks in
natural populations of infected insects that appear to be viral
reactivation (17, 33) caused by stress factors (26, 30,
33, 42) such as overcrowding, lack of food (43), or
thermal shock (24). The ingestion of heterologous viruses has also been shown to activate persistent viral infection (26, 30, 37, 42). Despite these reports of occasional observations of
persistently infected insects, the mechanisms that cause persistent baculovirus infection remain unknown.
The p35 gene is known as an apoptotic suppressor gene. The
P35 protein can act as an inhibitor of an interleukin-1 In the current study, we found that infection of Sf cells with vAcAnh,
a p35 null mutant of AcMNPV, results in
widespread apoptotic cell death. In contrast to the killing of all
infected cells by the wild-type virus, we consistently found that some cell clones survived the infection and became persistently infected, phenotypically resembling cell clones persistently infected with S. frugiperda nuclear polyhedrosis virus (36) and
Hz-1 virus (7, 9-11, 25, 31). Hz-1 virus is an unclassified
baculovirus-like insect virus (46). This novel, artificially
established, persistent viral infection resulting from mutation or
deletion of apoptotic suppressor gene p35 was reactivated by
transfection of the same gene. Persistent viral genomes propagated in
the persistently infected cells through passages, and the cells were
resistant to superinfection with both the wild-type and p35
mutant viruses. These findings may provide a novel continuous, nonlytic
baculovirus expression system for future biotechnical applications.
Cells and viruses.
S. frugiperda (fall armyworm)
Sf9 and Sf21AE cells and T. ni (cabbage looper) TN368 cells
were maintained at 26°C in TNM-FH medium supplemented with 8% fetal
bovine serum (Life Technologies). Wild-type AcMNPV, vAcAnh
(the annihilator, an AcMNPV mutant which lacks functional
P35; 13), vAcZ Construction of a virus with p35 deleted carrying a
lacZ gene.
The lacZ gene and a neomycin
resistance gene were inserted into plasmid pTSV (32),
resulting in plasmid pThsN90Z. The neomycin resistance gene
was driven by a heat shock promoter (44), and the
lacZ gene was driven by the pag-90 promoter. The pag-90
promoter is an immediate-early-type promoter derived from
pag1 (the gene which expresses the PAT1 transcript) of the
Hz-1 virus (10). Both genes were flanked by p94
and p35 sequences after insertion of homologous regions of
baculovirus p94 (801 bp, nucleotides
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Persistent Baculovirus Infection Results from
Deletion of the Apoptotic Suppressor Gene p35
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-converting enzyme-like protease (1, 3) and prevents cell death in a broad range of hosts, including Drosophila sp.
(23), Caenorhabditis elegans nematodes
(45), and mammal neural cells (35, 39). p35 is one of the 18 late expression factor (lef)
genes involved in the regulation of viral DNA replication and late gene
expression in Autographa californica multiple nuclear
polyhedrosis virus (AcMNPV)-infected cells (34).
The expression of p35 is not only required for optimal late
gene expression but is also necessary for blocking premature death of
infected Sf21 cells. The apoptotic response of cells to infection with
vAcAnh, an AcMNPV mutant defective in p35,
results in a significant reduction in viral yield in Spodoptera frugiperda (Sf) cells and larvae, but not in Trichoplusia
ni cells or larvae (14). The biological role of
p35 is thus suggested to be a host range determinant which
can act against host apoptotic defense mechanisms by antagonizing cell
death signals.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
p35 (described below; see Fig. 1A),
and vAsB6-1 (a recombinant p35 mutant carrying the inhibitor of the apoptosis gene of Cydia pomonella granulosis virus
[Cp-iap]; 15) were each propagated in
TN368 cells. Titers of the viruses were estimated by plaque assays
using TN368 cells.
115 to +685 relative
to the ATG start codon) and p35 (631 bp, nucleotides +219 to
+849 relative to the ATG start codon; 18) into
plasmid pThsN90Z, which produced transfer vector
pT
35hsN90Z (Fig. 1A).
These p94 and p35 specific fragments were
generated by PCR and further confirmed by DNA sequencing.

View larger version (26K):
[in a new window]
FIG. 1.
Recombinant virus or plasmid construction. (A)
Construction of vAcZ
p35, a recombinant AcMNPV which lacks
a p35 function. The deleted region between nucleotide
115
relative to the ATG start codon of p94 and nucleotide +219
relative to the ATG start codon of p35 was replaced with
both the lacZ and neo genes, and lacZ
was driven by an immediate-early-type pag-90 promoter of the Hz-1 virus
(10) and the neomycin resistance gene (neo) was
driven by a Drosophila hsp70 promoter. These two genes and
promoters are shown in newly constructed plasmid pThsN90Z.
Further insertion of lateral fragments containing the indicated regions
of the p94 and p35 genes into plasmid
pThsN90Z resulted plasmid pT
35hsN90Z. The
final constructed recombinant virus, which contains the exogenous
neo and lacZ genes and lacks the capability of
P35 expression, was named vAcZ
p35. ORF, open reading frame; SV40,
simian virus 40; mu, map units. (B) Organization of a
p35-containing plasmid for p35 expression.
Plasmid pKih35hN contains the complete open reading frame
of the p35 gene driven by the ie1 promoter (prm)
of AcMNPV. An hr5 enhancer sequence (677 bp;
22) was inserted upstream of the ie1
promoter. The neo gene is driven by a Drosophila
hsp70 promoter.
35hsN90Z
into TN368 cells. The recombinant virus, named vAcZ
p35, was cloned
by screening the transfected TN368 cells for blue plaques with
occlusion bodies following
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal) staining and was further verified in the infected Sf21 cells by the
lack of occlusion body formation. The antibiotic G418 (2 mg/ml) was
used in all of the screenings to eliminate the wild-type virus. The
recombinant viruses were further verified by restriction mapping of
their genomic DNAs and functional assay of their induction of apoptosis
upon infection of Sf21 cells.
Isolation of a stably transfected cell line expressing P35.
Plasmid pKih35hN contains the full open reading frame of
p35 (nucleotides
22 to +1003 relative to the ATG start
codon; 18) under the control of the AcMNPV
ie1hr5 promoter containing an upstream enhancer
hr5 repeat region (40). The plasmid also contains
a neomycin resistance gene under the control of the heat shock 70 promoter from pBluescript KSM+ (Stratagene). This plasmid,
pKih35hN (Fig. 1B), was transfected into cells by using
CellFECTIN in accordance with the manufacturer's (Life Technologies)
instructions. Neomycin-resistant clones were cultured in the presence
of 2-mg/ml G418 for 2 weeks, and individual clones of Sf21-p35-1,
Sf21-p35-2, and Sf21-p35-3 cells were isolated.
Estimation of the rate of persistently infected clone
formation.
Parental cells (Sf9 and Sf21) were seeded at a density
of 4 × 104 per well in a 96-well plate and infected
individually with Hz-1 virus, AcMNPV, virus vAcAnh or
vAcZ
p35 with p35 mutated or deleted, or revertant virus
vAsB6-1 at various concentrations. Seven to 10 days after infection,
the number of surviving cells was determined by trypan blue exclusion.
Colonies containing more than five cells were isolated and used for
further propagations into monolayers. Although some of the clones died
during propagation, the number of original colonies formed after
infection with a certain virus at a certain concentration reflected the
colony formation potential of the individual viruses.
Establishment of persistently infected cell lines.
Parental
cells (Sf9 and Sf21) at 2 × 105 per well in a 24-well
plate were inoculated with a virus with p35 mutated or
deleted (vAcAnh or vAcZ
p35) at a multiplicity of infection (MOI) of
50. Two weeks postinoculation, the surviving cell clones became
visible. Clones were isolated, transferred into a 96-well plate, and
grown for 7 to 10 days with a medium change once every 3 to 4 days. The
surviving clones were transferred to a 24-well plate and then, if they
grew, to larger plates or flasks. On average, ca. 3 to 6 clones per 10 original clones survived these transfers. Loss of clones during
transfers was attributed mainly to apoptotic cell death. Conditioned
medium (half fresh and half used) was used to culture these clones. Two
groups of persistently infected cell lines were established and used in
subsequent experiments. Persistently infected cell lines derived by
infection with vAcAnh were Sf9-vAc-1, Sf9-vAc-2, Sf9-vAc-3, and
Sf21-vAc-1. Persistently infected cell lines derived by infection with
vAcZ
p35 were Sf9-vAcZ
p35-1, Sf9-vAcZ
p35-2, and
Sf9-vAcZ
p35-3.
Detection of viral DNA by PCR. To detect very small amounts of viral DNA in persistently infected cells, DNA was amplified directly from cultured cells by PCR (see Fig. 3A). Cells were washed twice in phosphate-buffered saline and diluted to 106/ml. Ten microliters of this diluted suspension, corresponding to 104 cells, was lysed by adding 90 µl of detergent buffer (50 mM KCl, 10 mM Tris-HCl [pH 8.3], 0.1-mg/ml gelatin, 0.45% Nonidet P-40, 0.45% Tween 20) containing 6 µg of proteinase K. The diluted suspension was then incubated at 60°C for 1 h. After incubation, the proteinase K was inactivated at 95°C for 15 min.
Ten microliters of this lysate, corresponding to 103 cells, was amplified by PCR and analyzed by agarose gel electrophoresis. Serial 10× dilutions of plasmid pT
35hsN90Z were used as
molecular standards. These plasmid DNAs were amplified simultaneously
with the cell lysates to determine the quantity of viral DNA in the cells persistently infected with vAcAnh. Two negative controls, including a reaction mixture minus template DNA and a reaction mixture
containing only Sf9 cell lysate, were used. The primers used were
complementary to the 5' and 3' regions of the 801-bp fragment of the
p94 gene (Fig. 1). PCR products were fractionated on a 1.5%
agarose gel and transferred by vacuum blotter (Vacu GeneXL; Pharmacia
LKB Biotechnology) onto a nylon membrane. The membranes were probed
with a p94 gene fragment labeled with
[
-32P]dCTP by random priming in accordance with the
manufacturer's (Boehringer Mannheim) instructions.
Dot blot hybridization.
Total genomic DNAs were purified
from uninfected and persistently infected cells and blotted onto nylon
membranes by using the Hybri-Dot Manifold (Bio-Rad Laboratories)
blotting system. The membranes were probed with viral DNA labeled with
[
-32P]dCTP by random priming. The blot was visualized
by autoradiography and further quantified by using a PhosphorImager
(Molecular Dynamics).
RT-PCR and Southern analysis. Total cellular RNA was prepared from different cell clones by using Ultraspec RNA isolation reagent (Biotecx) in accordance with the manufacturer's instructions. To detect the expression of various immediate-early genes, 10 µg of total RNA was reverse transcribed by using an oligo(dT) primer and Moloney murine leukemia virus reverse transcriptase. Equal amounts of cDNA were amplified by PCR with specific primers for the viral ie0, ie1, and ie2 genes and the cellular gapdh gene.
The primers used for PCR were as follows: ie0, 5'-GGCAACGCAACATGATAAGAC and 3'-GTTCAAGGGTTGCACAGCTT, complementary to positions
11 to +720 relative to the ATG start
codon; ie1, 5'-GATCGTGAACAACCAAGTGA and
3'-GTTCAAGGGTTGCACAGCTT, complementary to positions
22 to +520 relative to the ATG start codon (12); ie2,
5'-AACAGTATCCTACCAGCCA and 3'-CCTCTACTTCTTCTTCGGGT,
complementary to positions
23 to +612 relative to the ATG start
codon (8); gapdh, 5'-GACGGACCCTCTGGAAAA and 3'-ACCAGCTGATGAGCTTGAC, corresponding to amino
acid residues 195 to 310 of the Drosophila melanogaster
gapdh gene (34).
Each PCR was carried out for 30 thermal cycles. Samples without Moloney
murine leukemia virus reverse transcriptase were also tested to ensure
that the fragment was amplified from mRNA. The reverse transcription
(RT) products were separated by electrophoreses in 1.2% agarose gels
and transferred to a MAGNA nylon transfer membrane (MSI) by a vacuum
blotter (Vacu GeneXL). The membrane was hybridized separately with
32P-labeled probes against the ie0,
ie1, ie2, and gapdh genes at 60°C
overnight by using a hybridization buffer containing 0.25 M
Na2HPO4 at pH 7.2, 1 mM EDTA, 7% sodium
dodecyl sulfate, 1% bovine serum albumin fraction V, and 10%
formamide.
Histochemical staining of
-galactosidase activity.
Cells
were fixed for 5 min at room temperature in a solution of 2%
formaldehyde and 2% glutaraldehyde in 150 mM NaCl and 15 mM
Na2HPO4 buffer. Cells were then washed twice
with 150 mM NaCl and 15 mM Na2HPO4 buffer and
stained with 1-mg/ml X-Gal in a buffer containing 5 mM
K3Fe(CN)6, K4Fe(CN)6,
and 5 mM MgCl2. The cells were stained overnight at 37°C
before microscopic examination.
Interference assay. Both the parental cells and persistently infected cells were inoculated with either wild-type AcMNPV or the p35 null mutants of AcMNPV at an MOI of 10, 1, or 0.1. After adsorption, the residual viruses were removed and the cells were incubated with culture medium at 26°C for 3 days. Viability of the cells was estimated by trypan blue exclusion.
Assay of virus release and reactivation in persistently infected
cells.
Persistently infected cells (2 × 105/well
in 24-well plates) were transfected with 1 µg of plasmid
pKih35hN (Fig. 1B) by using CellFECTIN (Life Technologies)
for the assay of viral reactivation (see Fig. 7). As a control,
parental Sf9 cells were transfected with pKih35hN, and at
24 h posttransfection, these cells were infected with mutant virus
vAcZ
p35 at an MOI of 10. The culture media were harvested at 6 days
posttransfection, and the titers of released viruses were determined by
plaque assay using TN368 cells.
| |
RESULTS |
|---|
|
|
|---|
Mutation or deletion of the p35 gene results in
persistent AcMNPV infection.
Two AcMNPV
mutants carrying either a mutation or a deletion at the p35
locus were studied, and the correlation of p35 mutation or
deletion with apoptosis induction in the infected cells and persistent
viral infection was identified. The first p35 mutant virus
was vAcAnh, the annihilator. This is an AcMNPV mutant with a
754-bp deletion in the p35 gene resulting in a truncated
p35 protein missing 132 amino acids from its carboxyl
terminus (13). The other mutant, a vAcZ
p35 virus with
p35 deleted, has the promoter and the 5' end up to +219 bp
of the p35 gene replaced with a lacZ gene which
is driven by an immediate-early-type promoter, pag-90 (10; Fig. 1A).
p35 virus (Fig. 2Ab),
most of the cells were lysed by apoptosis, and the remaining cells
consistently gave raise to typical persistently infected cell clones 7 days postinfection. Persistent infection did not result from infection
with the wild-type virus (Fig. 2Ac) or from infection with a
Cp-iap-rescued p35 mutant AcMNPV
(named vAsB6-1) (Fig. 2Ad) (5). These results suggest that
the repression of persistent viral infection is not due to a specific
p35 function but, instead, is more likely due to a general
effect related directly or indirectly to the blocking of cellular
apoptosis.
|
p35 could generate persistently infected clones. These clones were not obtained by infection with the wild type or the vAsB6-1 revertant at a wide range of titers (Fig. 2C). In these experiments, higher MOIs generated more colonies, suggesting that a specific virus
gene product(s) enhanced the formation of persistently infected clones.
When Sf21 cells are infected with AcMNPV with p35
mutated or deleted, there is a delay in the transcription and
translation of early and late viral genes, followed by a lack of very
late gene expression (14). Therefore, the specific virus
gene product that enhances the increasing number of persistently
infected cell clones must be either an early or a late viral gene
product or a virion protein which migrates into the cell upon viral
infection. The specific virus gene product for persistent clone
formation seems not to be propagative and could only be enriched by
infection at a higher MOI.
Detection of various amounts of viral DNAs with different gene
expressions in persistently infected cells.
In all of the cells
persistently infected with vAcAnh, viral DNA was not detectable by
Southern analysis (80 passages; data not shown) unless the viral DNA
was first amplified by PCR and then subjected to Southern hybridization
(Fig. 3A). The persistently infected
cells established by infection with vAcZ
p35 behaved differently from
those derived by infection with vAcAnh in terms of viral DNA content
and gene expression in some of the established cell lines. After
prolonged serial passages, higher viral DNA content was still
detectable by Southern analysis in the Sf9-vAcZ
p35-1, Sf9-vAcZ
p35-2, and Sf9-vAcZ
p35-3 cell lines than in cell lines established by infection with vAcAnh. Although the last tested cell
line, Sf9-vAcZ
p35-3, contained much less viral DNA than other lines
established by vAcZ
p35, its DNA content was still higher than that
found in cells established by infection with vAcAnh. During 80 to 90 passages, the pattern of restriction fragments showed that both the
lacZ and neomycin resistance genes in the persistent viral
genomes of Sf9-vAcZ
p35-1 and Sf9-vAcZ
p35-2 cells (Fig. 3Ba,
arrowheads) were deleted. In addition to these deletions, the viral
genome in Sf9-vAcZ
p35-2 may have a partially deleted XhoI
H or I fragment, or there may be a mixture of virus populations with
different genomic deletions. Dot blot hybridizations showed that the
genomes of Sf9-vAcZ
p35-1, Sf9-vAcZ
p35-2, and Sf9-vAcZ
p35-3
cells still contained relatively large amounts of viral DNA (8, 14, and
0.3%, respectively; Fig. 3Bb) compared with those of persistently
infected lines established by infection with vAcAnh.
|
p35, e.g., the Sf9-vAcZ
p35-1 and Sf9-vAcZ
p35-2 cell
lines (Fig. 4, lanes 13 and 14). The expression of all of the early genes tested from these two cell lines was relatively strong and not
distinguishable from the early gene expression of cells productively infected with the viruses, suggesting that the persistent viral genome
was still "alive" and that with the transfection of the p35 gene, mature virus particles may be generated. The
expression of early genes was not detectable in Sf9-vAcZ
p35-3 cells,
probably due to low viral DNA content or weak viral gene expression
(Fig. 4, lanes 15).
|
Expression of the engineered lacZ gene by persistently
infected cells.
LacZ activity of persistent viruses originally
derived by infection with lacZ gene-carrying virus
vAcZ
p35 was studied. Essentially all of the infected cells exhibited
LacZ activity upon initial viral infection. Once the persistently
infected cell clones were isolated, the cells went through an unstable
early passage stage. During these early passages, some 10 to 20% of
the cells went through apoptosis and died during each passage. At
passage 5, the percentage of apoptotic cells began to decrease and the
percentage of cells with LacZ activity was recorded. A high percentage
(ca. 50%) of the cell lines expressed LacZ activity during the early stage of culturing. These persistently infected cells grew slower than
did the parental cells, with a doubling time of roughly 27 to 30 h. The LacZ activities were observed for 50 to 60 passages (Fig.
5) over a 5- to 6-month period. After 65 passages, there was no longer detectable LacZ activity; however, large
amounts of viral genomic DNAs were still detectable and early gene
expression was evident in all of the cell lines (Fig. 3 and 4).
|
Persistently infected cells are resistant to superinfection with
wild-type or mutant AcMNPV.
Parental and persistently
infected cells were challenged with either vAcAnh or wild-type
AcMNPV at passage 90. Resistance to infection with these two
viruses was observed in two persistently infected cell lines, Sf9-vAc-1
and Sf9-vAc-2, whereas virus resistance was less evident in the
Sf9-vAc-3 and Sf21-vAc-1 cell lines. Significant virus resistance was
observed in cells persistently infected with vAcZ
p35. Among these
cells, only a few were killed by infection with vAcAnh or wild-type
AcMNPV at different viral dosages (Fig. 6, Sf9-vAcZ
p35-1, Sf9-vAcZ
p35-2,
and Sf9-vAcZ
p35-3).
|
p35 are significantly different in terms of the ability to
resist infection upon further viral challenges. This is likely due to the differences in viral DNA content and gene expression between these
two types of persistently infected cells, which may interfere with the
attachment, entrance, uncoating, gene expression, or maturation of the
invading viruses.
Release and reactivation of persistent viruses.
When cells
persistently infected with virus vAcZ
p35 were newly established,
infectious viruses could be detected in the media (data not shown). To
analyze whether these cells could still release virus after long
passages, the titers of infectious viruses present in the culture media
of different cell lines at 80 to 100 passages were estimated. No
infectious viruses could be detected in persistently infected cell
lines Sf21-vAc-1, Sf9-vAc-1, Sf9-vAc-2, and Sf9-vAc-3 (data not shown),
which were established by infection with vAcAnh. The production of low
viral titers could be detected in two persistently infected cell lines,
Sf9-vAcZ
p35-1 and Sf9-vAcZ
p35-2 (Fig.
7B, lanes 1 and 3), but not in
Sf9-vAcZ
p35-3 cells (Fig. 7B, lane 5), which were established by
infection with vAcZ
p35.
|
p35. This experiment showed that the p35
product significantly restored higher yields of vAcZ
p35 viral
progeny (Fig. 7A, lane 3) compared with vAcZ
p35 infection of Sf9
cells without p35 transfection (Fig. 7A, lane 2). Six days after transfection of plasmid pKih35hN into persistently
infected cell lines, the culture media were harvested and the yields of
released viruses were determined by plaque assays (Fig. 7B, lanes 2, 4, and 6). Compared with those of untransfected persistently infected cell
lines (Fig. 7B, lanes 1 and 3), yields of viral progeny from
Sf9-vAcZ
p35-1 and Sf9-vAcZ
p35-2 cells were increased, although
the difference was not significant when a log scale was used.
Interestingly, after p35 gene transfection, production of
viruses by non-virus-producing line Sf9-vAcZ
p35-3 was observed (Fig.
7B, lane 6). Another non-virus-producing persistently infected
cell line, Sf9-vAcZ
p35-4, was established later by infection with
the vAcZ
p35 virus, and further experiments showed that persistently infected viruses were also significantly activated by transfection with
p35 (data not shown). This result further confirms that
these four cell lines were persistently infected cells which were
subject to viral reactivation upon stimulation by p35
transfection.
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we demonstrated that deletion of the p35 gene from AcMNPV results in long-term association of the virus (or the viral genome) with host cells. Although it appears that deletion of p35 damages the virus and renders the viral genome inactive in the infected cells, several lines of evidence suggest that the infected cell and the viral genome actually exist in a state resembling persistent viral infection. The viral genomes were found to persist in persistently infected cells after a number of passages, and the results of Southern analysis showed that the viral genome, although it had one or two deletions, persisted in an intact form (Fig. 3Ba). Therefore, long-term persistence of viral DNAs in persistently infected cells was not due to random insertions of fragmented viral DNAs into host genomes. The persistent viral genome is still actively expressed and propagated following replication of the host genome during cellular passages. Infectious viral particles were continuously produced in many of the persistently infected cells, and infectious viruses were further stimulated or reactivated by p35 transfection in all of the cells tested (Fig. 7). The persistently infected cells were partially or highly resistant to superinfection with the wild-type or annihilator virus (Fig. 6). Resistance to infection with homologous viruses is a characteristic frequently observed in cells persistently infected with viruses (4, 16, 19, 20, 31, 47). This further strengthens our conclusion that cells were persistently infected. Collectively, many of the phenomena previously described are characteristics indistinguishable from those of Sf cells persistently infected with naturally derived S. frugiperda nuclear polyhedrosis virus (36).
Because infection with viruses with p35 mutated or deleted results in apoptotic cell death, it seems unlikely that persistent viral infection could be established. p35 has been referred to as one of the lef genes which are involved in expression of late baculovirus promoters in transient expression assays (34). We do not know the mechanism by which some cells are not susceptible to apoptotic death upon initial infection with mutant viruses. Our results showed that replication of viral genomes was still evident in persistently infected cells during passages; however, since the function of p35 is required for late gene expression, as a result, the maturation of the viruses in these survival cells was largely inhibited. Therefore, the generation of surviving cell clones may be the direct result of selection of Sf cells that express higher levels of host apoptotic suppressors. If those host apoptotic suppressors were sufficient to block or tolerate a weak apoptotic signal resulting from a low level of virus replication, persistent viral infection would be established. Those cells harboring viral genomes which replicate in a manner relatively similar to that of host genomes would then behave in the same way as persistently infected cells.
In our experiments, although both viruses vAcAnh and vAcZ
p35 could
induce the establishment of persistent viral infection, early gene
expression was only detectable in the cells infected with the latter
virus. This is probably due to the following two reasons. First, there
is a difference between vAcAnh and vAcZ
p35. vAcAnh can still produce
the P35 protein, although it is missing 132 amino acids from its
carboxyl terminus. vAcZ
p35 has no ability whatsoever to produce P35.
Thus, the truncated P35 produced by vAcAnh may still have some effect
on the establishment of a persistent viral infection, viral DNA
replication, or gene expression in the persistently infected viral
genome. Second, the viral genome content in persistently infected cells
as a result of vAcAnh infection is extremely low compared with that
from vAcZ
p35 infection. Therefore, even if early gene products are
expressed by infection with vAcAnh, they would likely not be
detectable. Certainly, we cannot rule out the possibility that other
differences between these two viruses exist; however, these two viruses
have important features in common with respect to the ability to induce
persistent viral infection, and this ability can be similarly blocked
by p35.
Persistently infected cells were found to resist superinfection with either the wild type or a virus with p35 mutated or deleted. During persistent infection, the existence of viral genomes or the expression of viral genes in the cell may make superinfected viral expression difficult due to the competition for cellular elements required for viral gene expression or DNA replication. It is also possible that the resistance of persistently infected cells to superinfection is due to factors other than the existence of persistent viral DNA or viral gene expression. The persistently infected cells may become resistant to superinfection due to the elimination of virus-binding sites (47) or mutations in the existing viral genome (2). Deletions other than the p35 gene in the viral genome were evident in Sf cells persistently infected with the virus with p35 deleted (Fig. 3Ba). It is possible that further mutations take place somewhere else in the viral genome. These extra deletions and mutations may cause resistance to the challenge of these cells with AcMNPV. All possible mechanisms for viral resistance will be examined in future studies by using these newly established persistent baculovirus infection cell lines.
In one of our previous studies, the promoter and the 5'-end coding
region of p35 were replaced with the insertion of a LacZ coding region which is driven by an immediate-early-type
pag1 promoter. pag1 is the only detectable gene
expressed during persistent Hz-1 virus infection (10). Thus,
the pag1 promoter may have a better chance of expressing the
gene product during persistent baculovirus infection as well. In the
current study, LacZ was expressed for long periods of time in cells
persistently infected with vAcZ
p35 (Fig. 5). Although LacZ activity
was not detectable after 65 passages, we have demonstrated the
successful establishment of a continuous baculovirus expression system
by using persistent viral infection. In subsequent experiments, we
found that the lack of lacZ gene expression after 65 passages was not due to diminished total viral genomes in persistently
infected cells, as very large amounts of viral DNAs were still
detectable. We determined that the real cause for elimination of
lacZ gene expression was deletion of the lacZ
gene in at least two of the persistently infected cell lines after
repeated passages (Fig. 3Ba).
It is possible that deletion of the viral genome was caused by a strong and continuous expression of the lacZ gene that may subsequently conflict with regional DNA replication in the persistent viral genome. This possibility seems unlikely, however, considering that continuous early gene expression did not result in deletion of these genes. Another possibility for specific deletion of the lacZ gene may be attributed to the p35 locus, where the lacZ gene is located. The p35 locus could be an unstable and easily deleted genomic region during viral persistence. Experiments intended to address this possibility are in progress in our laboratory.
The baculovirus expression vector system (BEVS) is a widely accepted tool for high-level protein expression. It is a productive viral infection system by which the protein of interest is produced by very late promoters accompanied by cell death. A continuous protein expression system created by stable transfection of a foreign gene into living insect cells has been reported to produce intact recombinant glycoproteins without obvious degradation, and the glycoproteins were secreted more completely than with a conventional lytic BEVS (28). It was later shown that biologically active eucaryotic secretory pathway proteins could be produced by stable transfection of a foreign gene with yields equivalent to that of a conventional BEVS (29). Our newly established persistent baculovirus infection could provide an alternative continuous protein expression system that may compare favorably, in some respects, with the stable transfection of insect cells.
Although improvements are still required before persistent baculovirus infection can be used as an efficient protein expression system, continuous protein expression using persistent viral infection may have several advantages over stable transfection of genes of interest into cells. Persistent baculovirus infection could use all of the versatile techniques and tools developed for a BEVS with only minor modifications. Its establishment requires no antibiotics or selection markers, and with future improvement of the persistent infection, it is possible that a much higher percentage of cells will become persistently infected upon initial viral infection. The persistently infected cell lines may be able to harbor a high level of genomic copies of the virus (more than 10%), thus providing a basis for high-level foreign protein expression. Immediate-early-type genes like ie1 are expressed during persistent infection; thus, the use of stronger intermediate or even late promoters of the persistent viral genomes for foreign protein expression will be possible. Since the capacity of the viral genome is enormous, it is possible to use persistent viral infection for introduction of multiple genes into cells, which is difficult to achieve by conventional stable DNA transfection.
Systems for the study of persistent baculoviral infections in insects are limited in number and rely on occasional observations of persistently virus-infected insects from field collections (26, 27, 37). Thus, our findings should provide a workable system for a more specific and detailed molecular analysis of persistent baculovirus infection. If persistent viral infection can be established in insects, the persistent viruses could be used to introduce foreign genes into insects for engineering of beneficial insects or analysis of insect physiology.
| |
ACKNOWLEDGMENTS |
|---|
We thank L. K. Miller for kindly providing the p35 gene and the vAcAnh and vAsB6-1 viruses and C. C. Wang and Douglas Platt for critical reading of the manuscript.
This research was supported by Academia Sinica and by grant NSC 87-2311-B-001-124 from the National Science Council, Taiwan, Republic of China.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute of Molecular Biology, Academia Sinica, Nankang, Taipei 115, Taiwan, Republic of China. Phone: 886-2-2788-2697. Fax: 886-2-2788-2697 or 886-2-2782-6085. E-mail: mbycchao{at}ccvax.sinica.edu.tw.
Present address: Department of Biology, National Cheng-Kung
University, Tainan 701, Taiwan, Republic of China.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ahmad, M.,
S. M. Srinivasula,
L. Wang,
G. Litwack,
T. Fernandes, and E. S. Alnemri.
1997.
Spodoptera frugiperda caspase-1, a novel insect death protease that cleaves the nuclear immunophilin FKBP46, is the target of the baculovirus antiapoptotic protein p35.
J. Biol. Chem.
272:1421-1424 |
| 2. | Berkowitz, R. D., and S. P. Goff. 1993. Point mutations in Moloney murine leukemia virus envelope protein: effects on infectivity, virion association, and superinfection resistance. Virology 196:748-757[Medline]. |
| 3. | Bertin, J., S. M. Mendrysa, D. J. LaCount, S. Gaur, J. F. Krebs, R. C. Armstrong, K. J. Tomaselli, and P. D. Friesen. 1996. Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease. J. Virol. 70:6251-6259[Abstract]. |
| 4. |
Billecocq, A.,
P. Vialat, and M. Bouloy.
1996.
Persistent infection of mammalian cells by Rift Valley fever virus.
J. Gen. Virol.
77:3053-3062 |
| 5. |
Birnbaum, M. J.,
R. J. Clem, and L. K. Miller.
1994.
An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs.
J. Virol.
68:2521-2528 |
| 6. | Blissard, G. W., and G. F. Rohrmann. 1990. Baculovirus diversity and molecular biology. Annu. Rev. Entomol. 35:127-155[Medline]. |
| 7. | Burand, J. P., C. Y. Kawanishi, and Y. S. Huang. 1986. Persistent baculovirus infections, p. 159-175. In R. R. Granados, and B. A. Federici (ed.), The biology of baculovirus. CRC Press, Inc., Boca Raton, Fla. |
| 8. | Carson, D. D., M. D. Summer, and L. A. Guarino. 1991. Molecular analysis of a baculovirus regulatory gene. Virology 182:279-286[Medline]. |
| 9. | Chao, Y.-C., M. Hamblin, and H. A. Wood. 1990. The physical map of Hz-1 viral genome from standard and defective interference viral particles. J. Gen. Virol. 71:1265-1270. |
| 10. |
Chao, Y.-C.,
S.-T. Lee,
M.-C. Chang,
H.-H. Chen,
S.-S. Chen,
T.-Y. Wu,
F.-H. Liu,
E.-L. Hsu, and R. F. Hou.
1998.
A 2.9-kilobase noncoding nuclear RNA functions in the establishment of persistent Hz-1 viral infection.
J. Virol.
72:2233-2245 |
| 11. |
Chao, Y.-C.,
H. A. Wood,
C.-Y. Chang,
H.-J. Lee,
W.-C. Shen, and H.-T. Lee.
1992.
Differential expression of Hz-1 baculovirus genes during productive and persistent viral infections.
J. Virol.
66:1442-1448 |
| 12. |
Chisholm, G. E., and D. J. Henner.
1988.
Multiple early transcripts and splicing of the Autographa californica nuclear polyhedrosis virus IE-1 gene.
J. Virol.
62:3193-3200 |
| 13. |
Clem, R. J.,
M. Fechheimer, and L. K. Miller.
1991.
Prevention of apoptosis by a baculovirus gene during infection of insect cells.
Science
254:1388-1390 |
| 14. |
Clem, R. J., and L. K. Miller.
1993.
Apoptosis reduces both the in vitro replication and the in vivo infectivity of a baculovirus.
J. Virol.
67:3730-3738 |
| 15. |
Crook, M. E.,
R. J. Clem, and L. K. Miller.
1993.
An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif.
J. Virol.
67:2168-2174 |
| 16. |
Doller, E.,
J. Aucker, and A. Weissbach.
1979.
Persistence of herpes simplex virus type 1 in rat neurotumor cells.
J. Virol.
29:43-50 |
| 17. | Evans, H. F., and K. A. Harrap. 1982. Persistence of insect viruses, p. 57-96. In B. W. J. Mahy, A. C. Minson, and G. K. Darby (ed.), Virus persistence SGM Symposium. Cambridge University Press, Cambridge, England. |
| 18. |
Friesen, P. D., and L. K. Miller.
1987.
Divergent transcription of early 35- and 94-kilodalton protein genes encoded by the HindIII K genome fragment of the baculovirus Autographa calofornica nuclear polyhedrosis virus.
J. Virol.
61:2264-2272 |
| 19. | GilFernandez, C., and D. Garcia-Villalon. 1988. A model virus-cell system to study the persistence of African swine fever virus. Arch. Virol. 100:161-169[Medline]. |
| 20. |
Gorska-Flipot, I.,
M. Huang,
M. Cantin,
E. Rassart,
G. Massé, and P. Jolicoeur.
1992.
U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses.
J. Virol.
66:7201-7210 |
| 21. | Granados, R. R., T. Nguyen, and B. Cato. 1978. An insect cell line persistently infected with a baculovirus-like particle. Intervirology 10:309-317[Medline]. |
| 22. |
Guarino, L. A., and M. D. Summer.
1986.
Interspersed homologous DNA of Autographa californica nuclear polyhedrosis virus enhances delayed-early gene expression.
J. Virol.
60:215-223 |
| 23. | Hay, B. A., T. Wolff, and G. M. Rubin. 1994. Expression of baculovirus p35 prevents cell death in Drosophila. Development 120:2121-2129[Abstract]. |
| 24. | Himeno, M., F. Matsubara, and K. Hayashiya. 1973. The occult virus of nuclear polyhedrosis of the silkworm larvae. J. Invertebr. Pathol. 22:292-295. |
| 25. |
Huang, Y.-S.,
M. Hedberg, and C. Y. Kawanishi.
1982.
Characterization of the DNA of a nonoccluded baculovirus, Hz-1V.
J. Virol.
43:174-181 |
| 26. | Hughes, D. S., R. D. Possee, and L. A. King. 1993. Activation and detection of a latent baculovirus resembling Mamestra brassicae nuclear polyhedrosis virus in M. brassicae insects. Virology 194:608-615[Medline]. |
| 27. | Hughes, D. S., R. D. Possee, and L. A. King. 1997. Evidence for the presence of a low-level, persistent baculovirus infection of Mamestra brassicae insects. J. Gen. Virol. 78:1801-1805[Abstract]. |
| 28. | Jarvis, D. L., J. G. W. Fleming, G. R. Kovacs, M. D. Summers, and L. A. Guarino. 1990. Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. Bio/Technology 8:956-958[Medline]. |
| 29. | Jarvis, D. L., C. Weinkauf, and L. A. Guarino. 1996. Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells. Protein Expr. Purif. 8:191-203[Medline]. |
| 30. | King, L. A., and R. D. Possee. 1994. Advances in insect virology. Adv. Insect Physiol. 25:2-73. |
| 31. |
Lee, J.-C.,
H.-H. Chen,
H.-L. Wei, and Y.-C. Chao.
1993.
Superinfection-induced apoptosis and its correlation with the reduction of viral progeny in cells persistently infected with Hz-1 baculovirus.
J. Virol.
67:6989-6994 |
| 32. | Lee, S.-T., S.-M. Yu, E.-L. Hsu, and Y.-C. Chao. 1995. Identification of a very early promoter of Hz-1 virus using a novel dual-expression shuttle vector. Nucleic Acids Res. 22:4683-4689. |
| 33. | Longworth, J. F., and J. C. Cunningham. 1968. The activation of occult nuclear-polyhedrosis viruses by foreign nuclear polyhedra. J. Invertebr. Pathol. 10:361-367. |
| 34. | Lu, A., and L. K. Miller. 1995. The role of eighteen late expression factor genes in transcription and DNA replication. J. Virol. 69:975-982[Abstract]. |
| 35. |
Martinou, I.,
P. A. Fernandez,
M. Missotten,
E. White,
B. Allet,
R. Sadoul, and J. C. Martinou.
1995.
Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation.
J. Cell Biol.
128:201-208 |
| 36. | McIntosh, A. H., and C. M. Ignoffo. 1981. Establishment of a persistent baculovirus infection in a lepidopteran cell line. J. Invertebr. Pathol. 38:395-403. |
| 37. | McKinley, D. J., D. A. Brown, C. C. Payne, and K. A. Harrap. 1981. Cross infectivity and activation studies with four baculoviruses. Entomophaga 26:79-90. |
| 38. |
Miller, L. K., and K. P. Dawes.
1979.
Physical map of the DNA genome of Autographa californica nuclear polyhedrosis virus.
J. Virol.
29:1044-1045 |
| 39. | Rabizadeh, S., D. J. LaCount, P. D. Friesen, and D. E. Bredesen. 1993. Expression of the baculovirus p35 gene inhibits mammalian cell death. J. Neurochem. 61:2318-2321[Medline]. |
| 40. |
Rodems, S. M., and P. D. Friesen.
1993.
The hr5 transcriptional enhancer stimulates early expression from the Autographa californica nuclear polyhedrosis virus genome but is not required for virus replication.
J. Virol.
67:5776-5785 |
| 41. |
Smith, G. E., and M. D. Summers.
1979.
Restriction maps of five Autographa californica MNPV variants, Trihoplusia ni MNPV, and Galleria mellonella MNPV DNAs with endonucleases SmaI, KpnI, BamHI, SalcI, XhoI, and EcoRI.
J. Virol.
30:828-838 |
| 42. | Smith, K. M. 1963. The cytoplasmic virus diseases, p. 457-497. In E. A. Steinhaus (ed.), Insect pathology: an advanced treatise, vol. 1. Academic Press, Inc., New York, N.Y. |
| 43. | Steinhaus, E. A., and J. P. Dineen. 1960. Observations on the role of stress in a granulosis of the variegated cutworm. J. Insect Pathol. 2:55-65. |
| 44. |
Steller, H., and V. Pirrotta.
1986.
P transposons controlled by the heat shock promoter.
Mol. Cell. Biol.
6:1640-1649 |
| 45. | Sugimoto, A., P. D. Friesen, and J. H. Rothman. 1994. Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans. EMBO J. 13:2023-2028[Medline]. |
| 46. | Volkman, L. E., G. W. Blissard, P. Friesen, B. A. Keddie, R. Possee, and D. A. Theilmann. 1995. Virus taxonomy: the classification and nomenclature of viruses. Arch. Virol. 6(Suppl. 3):104-113. |
| 47. |
Wang, H.,
E. Klamo,
S. E. Kuhmann,
S. L. Kozak,
M. P. Kavanaugh, and D. Kabat.
1996.
Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter.
J. Virol.
70:6884-6891 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»